ePrints

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

Lookup NU author(s): Professor Derek Mann

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Background/Aims Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are the hepatic manifestation of metabolic syndrome. However, its therapeutic strategy has not been established. Recently, an angiotensin II type 1 receptor blocker, telmisartan (Tel), has received a great deal of attention as a therapeutic tool for metabolic syndrome. The aim of this study was to investigate the efficacy and mechanisms of Tel on a murine NASH model. Methods C57BL/6 mice were fed a methionine- and choline-deficient high-fat diet (MCDHF) or a standard diet with/without the administration of Tel (10 mg/kg/day) for 8 weeks. Results MCDHF feeding induced marked steatohepatitis with macrophage infiltration. Tel attenuated liver steatosis with decreased hepatic triglycerides (P

Publication metadata

Author(s): Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara M, Mann DA, Sugiyama T

Publication type: Article

Publication status: Published

Journal: Liver International

Year: 2009

Volume: 29

Issue: 7

Pages: 988-996

ISSN (print): 1478-3223

ISSN (electronic): 1478-3231

Publisher: Wiley-Blackwell Munksgaard

URL: http://dx.doi.org/10.1111/j.1478-3231.2009.02006.x

DOI: 10.1111/j.1478-3231.2009.02006.x

Altmetrics

Share